WSG Co., Ltd.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

WSG Co., Ltd. - overview

Established

2020

Location

Busan, -, South Korea

Primary Industry

Industrial Machinery

About

WSG Co. , Ltd. , based in South Korea, specializes in providing packaged product solutions for life sciences and biopharmaceuticals, along with ultra-high purity stainless solutions for microelectronics and semiconductors. Founded in 2020 in Busan, South Korea, WSG Co.


, Ltd. focuses on tailored solutions for the life sciences and biopharmaceutical industries. The founding team includes Dmitry Gilev and Vitaliy Ishutin, with Jose Usher serving as CEO. The company has successfully raised a total of KRW 8 billion in its latest funding round on March 15, 2023, from returning investor Sneak Peek Investment, contributing to a total amount raised of KRW 8 billion.


The current valuation of the company stands at KRW 103,343. 826 million. WSG CREST delivers a wide array of packaged solutions to the biopharmaceutical and life sciences sectors, including single-use products, tube and fittings systems, and cell culture media. Their ultra-high purity stainless products are vital for semiconductor and microelectronics manufacturing, addressing issues such as contamination prevention and enhancing operational efficiency, catering to a global clientele.


In 2023, WSG CREST reported a revenue of KRW 38,822,644. 6 and an EBITDA of KRW 4,299,996. 5, primarily operating on a B2B model that fosters long-term partnerships with clients in high-demand sectors, ensuring compliance with stringent quality standards. WSG Co.


, Ltd. plans to leverage its recent venture funding of KRW 8 billion to expand its product line, with upcoming launches targeting enhanced efficiency in laboratory processes expected in late 2023. The company aims to penetrate new markets in North America and Europe by mid-2024, focusing on building partnerships with biopharmaceutical and semiconductor manufacturing clients.


Current Investors

CKD Venture Capital, Shinhan Securities, WONIK Investment Partners

Primary Industry

Industrial Machinery

Sub Industries

Biotechnology, Automobiles, Other Vehicles & Parts, Industrial Machinery, Semiconductor Equipment & Testing

Website

www.wsgcrest.com

Verticals

Manufacturing

Company Stage

Series B

Total Amount Raised

Subscriber access only

WSG Co., Ltd. - timeline of key events

Blurred Background

Want to see the Timeline of Key Events?

Request a demo for full access to this profile.

WSG Co., Ltd. - financials

Fiscal Year EndedDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025
Revenue (USD)18,011,811,26435,026,474,44759,919,773,415---
% Revenue Growth (YoY)-94.5%71.1%---
EBITDA (USD)1,820,537,9383,612,985,6355,828,402,384---
Operating Income (USD)1,034,842,5842,063,245,5114,296,523,651---
Operating Margin5.7%5.9%7.2%---
% EBITDA Margin10.1%10.3%9.7%---
NET Income (USD)736,755,6594,633,846,6631,787,749,237---
% Net Margin4.1%13.2%3.0%---

WSG Co., Ltd. - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.